Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SYNGR2 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
mRNA | EXOSC1 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | ZNF550 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | TOR3A | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | CNPY4 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | PRKAR2A | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | DOPEY1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | ASCL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | HFM1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | ZNF814 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |